Aurinia Pharmaceuticals Inc Ordinary Shares Share Price
NASDAQ: AUPH | Mid CapAurinia Pharmaceuticals Inc Ordinary Shares Stock Performance
Open $15.41 | Prev. Close $15.36 | Circuit Range N/A |
Day Range $15.34 - $15.58 | Year Range $10.46 - $19.25 | Volume 29,480 |
Average Traded $15.48 |
Aurinia Pharmaceuticals Inc Ordinary Shares Share Price Today
As of 12 August 2026, Aurinia Pharmaceuticals Inc Ordinary Shares's share price is $15.44. The stock opened at $15.41, compared to its previous close of $15.36. During today's trading session, Aurinia Pharmaceuticals Inc Ordinary Shares's share price traded between $15.34 and $15.58, with an average price of $15.46. Over the past 52 weeks, the stock has recorded a high of $19.25 and a low of $10.46. In terms of performance, Aurinia Pharmaceuticals Inc Ordinary Shares's share price has risen by 8.89% over the last six months and is up 28.67% on a year-on-year basis.
Aurinia Pharmaceuticals Inc Ordinary Shares Share Price Chart
Aurinia Pharmaceuticals Inc Ordinary Shares Stock Fundamentals & Key Indicators
Market Cap $2.07B | PE Ratio (TTM) 7.21 | Dividend Yield N/A |
EPS (TTM) $2.14 | Revenue (TTM) $283.06M | Return On Equity (TTM) 49.40% |
Profit Margin 101.47% | Debt to Equity 0.16 | Quarterly Earnings Growth YoY 119.87% |
Aurinia Pharmaceuticals Inc Ordinary Shares Quarterly Profit & Loss
All figures in USD
Aurinia Pharmaceuticals Inc Ordinary Shares Annual Profit & Loss
All figures in USD
About Aurinia Pharmaceuticals Inc Ordinary Shares
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.
Aurinia Pharmaceuticals Inc Ordinary Shares Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $14.76 | $15.44 | +3.90% |
Jul 2026 | $17.05 | $14.86 | -12.43% |
Jun 2026 | $15.38 | $16.97 | +10.73% |
May 2026 | $15.29 | $15.32 | -0.36% |
Apr 2026 | $15.16 | $15.38 | +3.64% |
Mar 2026 | $14.38 | $14.84 | +4.65% |
Feb 2026 | $14.63 | $14.18 | -2.48% |
Jan 2026 | $15.77 | $14.54 | -8.73% |
Dec 2025 | $16.09 | $15.93 | -1.23% |
Nov 2025 | $13.26 | $16.13 | +22.37% |
Oct 2025 | $11.04 | $13.18 | +19.17% |
Sep 2025 | $11.92 | $11.06 | -7.83% |
AUPH Share Price FAQs
What is Aurinia Pharmaceuticals Inc Ordinary Shares share price today?
What is the 52 week high and 52 week low of Aurinia Pharmaceuticals Inc Ordinary Shares stock?
What is AUPH's market capitalisation today?
What is AUPH's net income for the last quarter?
What is the 5 year returns of AUPH?
What is the high & low stock price of AUPH today?
Can I buy AUPH shares in India?